GARS1 and neuropathy: To gauge the human relevance of this phenotype, we assessed endosome transport in a second CMT2D mouse model, GarsΔETAQ/+, which carries a deletion in endogenous mouse Gars modeling a mutation identified in a patient presenting with severe, early-onset neuropathy (34).